Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji

We describe an outbreak of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup C in Fiji. We created surveillance case definitions and collected data by using standard investigation forms. Bacterial identification, antimicrobial susceptibility testing, and PCR were perfor...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2025-01, Vol.31 (1), p.32-40
Main Authors: Strobel, Aneley Getahun, Sahukhan, Aalisha, Ratu, Anaseini, Kailawadoko, Jimaima, Koroituku, Isireli, Singh, Shalini, McEwen, Samuel, Baleivanualala, Sakiusa, Wilmot, Mathilda, Matanitobua, Silivia, Stevens, Kerrie, Vesikula, Anaseini, Cabemaiwai, Talica, Cooper, Raquel, Taufa, Mere, Tadrau, Jokaveti, Horan, Kristy, Faktaufon, Daniel, Howden, Benjamin P, Rafai, Eric
Format: Article
Language:English
Subjects:
Adolescent
Adult
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
antimicrobial resistance
Bacteria
Child
Child, Preschool
Disease Outbreaks
drug resistance
Drug Resistance, Multiple, Bacterial
Female
Fiji - epidemiology
Humans
Incidence
Infant
Male
Meningitis, Meningococcal - drug therapy
Meningitis, Meningococcal - epidemiology
Meningitis, Meningococcal - microbiology
meningitis/encephalitis
meningococcal C
Microbial Sensitivity Tests
Middle Aged
Neisseria meningitidis
Neisseria meningitidis, Serogroup C - drug effects
Neisseria meningitidis, Serogroup C - genetics
Neisseria meningitidis, Serogroup C - isolation & purification
Young Adult
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We describe an outbreak of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup C in Fiji. We created surveillance case definitions and collected data by using standard investigation forms. Bacterial identification, antimicrobial susceptibility testing, and PCR were performed in Fiji. Molecular testing was conducted at the Microbiological Diagnostic Unit in Melbourne, Victoria, Australia. During January 2016-December 2018, a total of 96 confirmed or probable IMD cases were reported. Of case-patients, 61.5% (59/96) were male and 38.5% (37) female, 84.4% (81) were indigenous people of Fiji, and 70.8% (68) were children
ISSN:1080-6059
1080-6040
1080-6059
DOI:10.3201/eid3101.240476